Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (adjunctive treatment)
* Premedication for surgical procedures
* Sedation
## Adult Dosing
* **Anxiety:** 0.5-2 mg orally 2-3 times daily. Maximum daily dose typically 10 mg.
* **Insomnia:** 1-2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. If seizures persist or recur after 5-10 minutes, a second dose of 4 mg may be administered.
* **Premedication:** 2-4 mg intramuscularly or intravenously 1-2 hours before surgery.
* **Sedation (ICU):** Titrate IV dose to achieve desired level of sedation. Typical initial doses range from 0.02-0.1 mg/kg/hour infusion, though continuous infusions are more common in practice and titration is highly individualized.
Dosing may vary based on specific indication and patient factors; consult local protocols.
## Pediatric Dosing
Dosing in children is highly variable and should be based on age, weight, and clinical condition.
* **Anxiety:** Doses of 0.02-0.06 mg/kg/dose orally or intramuscularly every 4-8 hours have been reported, not to exceed adult doses.
* **Status Epilepticus:** 0.1 mg/kg intravenously or intramuscularly, not to exceed 4 mg per dose.
Use in pediatric patients requires careful consideration due to potential for paradoxical reactions and respiratory depression.
## Dose Adjustments
* **Hepatic Impairment:** Reduce dose.
* **Renal Impairment:** No dose adjustment generally required for mild to moderate impairment, but caution and potential dose reduction may be warranted in severe impairment.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, amnesia.
Serious: Respiratory depression, paradoxical reactions (agitation, rage), dependence, withdrawal symptoms, coma, hypotension.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline, Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam plasma concentrations.
## Monitoring
* Respiratory rate and depth.
* Level of consciousness and sedation.
* Blood pressure.
* Signs of dependence and withdrawal (especially with prolonged use or abrupt discontinuation).
## Clinical Pearls
* Lorazepam is available in oral, intravenous, and intramuscular formulations.
* Intravenous administration for status epilepticus should be given slowly to minimize respiratory and cardiovascular depression.
* Tolerance, psychological and physical dependence may develop, even at therapeutic doses.
* Abrupt discontinuation can lead to withdrawal symptoms, which may be severe. Tapering of the dose is recommended.
* Consider lorazepam's potential for accumulation in patients with hepatic impairment.
***
*Disclaimer: This information is for educational purposes and should not substitute for professional medical advice. Always consult the most current prescribing information and a qualified healthcare provider for decisions regarding patient care.*
